Jonathan excels at translating scientific advances into preclinical, and clinical stage programs. He is a problem solver and a disruptive innovator, with major contributions that include the production of extracellular vesicles for nonviral gene delivery, functional human platelets from stem cells, and the invention of bioreactor platforms to scale cell culture.

Before STRM.BIO, Jonathan was CEO & CSO of Platelet BioGenesis (now Stellular Bio), which he took from a startup concept to a Series A-1 company of over 40 employees. Jonathan was also a professor and lecturer at Harvard Medical School, where he guided dozens of students toward rewarding careers in medicine and biopharma. He is a frequent speaker at scientific conferences, entrepreneurship meetings, and thought leadership events around the world.

Jonathan earned his Ph.D. in biochemistry and molecular biology from the University of British Columbia and completed his postdoctoral research fellowship in hematology at Harvard Medical School.